封面
市場調查報告書
商品編碼
1600229

智慧吸入器市場:按產品類型、適應症、分銷管道分類 - 全球預測 2025-2030

Smart Inhalers Market by Product Type (Dry Powder Inhalers, Metered-Dose Inhalers), Indication (Asthma, COPD), Distribution Channel - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年智慧吸入器市值為11.8億美元,預計2024年將達到14.5億美元,複合年成長率為22.84%,到2030年將達到49.8億美元。

智慧吸入器是先進的呼吸系統護理設備,整合了感測器和行動應用程式等技術,可追蹤和最佳化氣喘和慢性阻塞性肺病等疾病的用藥依從性。對智慧吸入器的需求源於提高用藥依從性的迫切需要,傳統吸入器導致依從性差,導致症狀控制不佳並增加醫療費用。這些設備提供即時藥物監測、使用情況追蹤和自動管理記錄,以提高患者參與度和健康結果。主要最終用戶包括希望利用資料加強疾病管理和治療研究的個別患者、醫療保健提供者和研究機構。

主要市場統計
基準年[2023] 11.8億美元
預測年份 [2024] 14.5億美元
預測年份 [2030] 49.8億美元
複合年成長率(%) 22.84%

關鍵的成長要素包括呼吸系統疾病的日益普及、對個人化醫療保健的需求不斷增加以及物聯網設備的技術進步。政府舉措的增加、有利的報銷政策和監管支持將進一步推動市場滲透。 COVID-19 大流行加速了數位醫療保健的採用,也為智慧吸入器市場帶來了動力。關鍵的發展機會在於開拓的新興市場以及配備人工智慧和機器學習的多功能智慧吸入器的開發,以進行病情惡化預測分析。

然而,市場成長面臨高成本、資料隱私問題以及低度開發地區缺乏意識和基礎設施等挑戰。此外,技術複雜性以及不斷改進和檢驗的需要也是主要障礙。

創新和研究應著重於增強設備連接性、擴大與各種吸入藥物的兼容性以及簡化使用者介面以促進更廣泛的採用。開發將智慧吸入器與全面的數位健康生態系統相結合的整合平台具有潛力,提供無縫的患者與醫生互動和個人化的治療計劃。市場正在快速成長,但需要靈活的適應和持續的研發投資來解決限制。進入新興市場的公司正在尋求與科技公司和醫療保健提供者合作,共同開發滿足這些多方面需求的解決方案,同時確保強大的資料安全性和用戶信任。

市場動態:揭示快速發展的智慧吸入器市場的關鍵市場洞察

供需的動態交互作用正在改變智慧吸入器市場。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球呼吸系統疾病盛行率不斷上升
    • 人們越來越意識到數位健康和​​連網型設備的好處
  • 市場限制因素
    • 開發智慧吸入器成本高昂
  • 市場機會
    • 更多新型智慧吸入器介紹
    • 智慧吸入器製造商與軟體公司之間的數位健康夥伴關係
  • 市場挑戰
    • 智慧吸入器的技術局​​限性

波特五力:駕馭智慧吸入器市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解智慧吸入器市場的外部影響

外部宏觀環境因素在塑造智慧吸入器市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解智慧吸入器市場的競爭格局

對智慧吸入器市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣智慧吸入器市場供應商的績效評估

FPNV定位矩陣是評估智慧吸入器市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商,從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製智慧吸入器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,智慧吸入器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機,並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球呼吸道疾病流行
      • 人們越來越意識到數位健康和​​連網型設備的好處
    • 抑制因素
      • 智慧吸入器開發成本高
    • 機會
      • Novel Rise 推出智慧吸入器
      • 智慧吸入器製造商與軟體公司之間的數位健康夥伴關係
    • 任務
      • 智慧型吸入器的某些技術限制
  • 市場區隔分析
    • 產品類型:乾粉吸入器擴大用於簡化給藥過程。
    • 分銷管道:透過線上分銷管道擴大智慧吸入器產品
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章智慧吸入器市場:依產品類型

  • 乾粉吸入器
  • 定量吸入器

第7章智慧吸入器市場(按適應症)

  • 氣喘
  • 慢性阻塞性肺病

第8章智慧吸入器市場:依分銷管道分類

  • 離線
    • 醫院藥房
    • 零售藥房
  • 線上

第9章美洲智慧吸入器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太智慧吸入器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲智慧吸入器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • 由 NHS 資助的萊斯特研究使用智慧吸入器來加強高風險兒童的氣喘管理,並旨在更廣泛地採用。
    • FDA核准Astra Zeneca創新 Hailie Smartinhaler 用於吸入器
    • Teva 的智慧吸入器 GoResp Digihaler 在英國推出
  • 戰略分析和建議

公司名單

  • 3M Company
  • Adherium Limited
  • AptarGroup, Inc.
  • Boehringer Ingelheim group
  • Cipla Limited
  • Cognita Labs, LLC
  • Cohero Health, Inc.
  • FindAir Sp. z oo
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals
  • Nemera Development SA
  • Omron Corporation
  • OPKO Health, Inc.
  • PARI GmbH
  • ResMed Inc.
  • Sensirion Holding AG
  • Teva Pharmaceutical Industries Limited
  • Vectura Group Limited
  • Vectura Group Ltd.
Product Code: MRR-430D42AA0D6F

The Smart Inhalers Market was valued at USD 1.18 billion in 2023, expected to reach USD 1.45 billion in 2024, and is projected to grow at a CAGR of 22.84%, to USD 4.98 billion by 2030.

Smart inhalers are advanced respiratory management devices that integrate technology, such as sensors and mobile applications, to track and optimize medication adherence for conditions like asthma and COPD. The necessity for smart inhalers arises from the urgent need to improve medication compliance, which stands low with traditional inhalers, contributing to uncontrolled symptoms and higher healthcare costs. These devices offer real-time medication monitoring, usage tracking, and automatic dose recording, enhancing patient engagement and health outcomes. Primary end-users encompass individual patients, healthcare providers, and research institutions aiming to leverage data for enhanced disease management and therapeutic research.

KEY MARKET STATISTICS
Base Year [2023] USD 1.18 billion
Estimated Year [2024] USD 1.45 billion
Forecast Year [2030] USD 4.98 billion
CAGR (%) 22.84%

Key growth factors include the increasing prevalence of respiratory diseases, the rising demand for personalized healthcare, and technological advancements in IoT devices. Increased governmental initiatives, favorable reimbursement policies, and regulatory support further drive market penetration. Digital healthcare adoption accelerated by the COVID-19 pandemic, also lends momentum to the smart inhalers market. Key opportunities lie within untapped emerging markets and in the development of multi-functional smart inhalers equipped with AI and machine learning for predictive analytics of exacerbations.

However, market growth faces challenges such as high costs, data privacy concerns, and a lack of awareness and infrastructure in underdeveloped regions. Moreover, technical complexities and the need for constant improvements and validation pose significant barriers.

Innovation and research should focus on enhancing device connectivity, expanding compatibility with various inhaled medications, and simplifying user interfaces to ensure broader adoption. There is potential in developing integrated platforms that combine smart inhalers with comprehensive digital health ecosystems, offering seamless patient-physician interaction, and personalized treatment plans. The market, while burgeoning, demands agile adaptation and continual investment in R&D to address limitations. Companies entering the market should focus on collaborations with tech firms and healthcare providers to co-develop solutions that address these multifaceted needs while ensuring robust data security and user trust.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Inhalers Market

The Smart Inhalers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of respiratory diseases globally
    • Rising awareness associated withthe benefits of digital health and connected devices
  • Market Restraints
    • High cost of development of smart inhalers
  • Market Opportunities
    • Rising introduction of novel smart inhalers
    • Digital health partnerships between smart inhaler manufacturers and software companies
  • Market Challenges
    • Certain technological limitations with the smart inhaler

Porter's Five Forces: A Strategic Tool for Navigating the Smart Inhalers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Inhalers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Inhalers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Inhalers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Inhalers Market

A detailed market share analysis in the Smart Inhalers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Inhalers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Inhalers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Inhalers Market

A strategic analysis of the Smart Inhalers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Inhalers Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adherium Limited, AptarGroup, Inc., Boehringer Ingelheim group, Cipla Limited, Cognita Labs, LLC, Cohero Health, Inc., FindAir Sp. z o. o., GlaxoSmithKline PLC, Glenmark Pharmaceuticals, Nemera Development S.A., Omron Corporation, OPKO Health, Inc., PARI GmbH, ResMed Inc., Sensirion Holding AG, Teva Pharmaceutical Industries Limited, Vectura Group Limited, and Vectura Group Ltd..

Market Segmentation & Coverage

This research report categorizes the Smart Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Dry Powder Inhalers and Metered-Dose Inhalers.
  • Based on Indication, market is studied across Asthma and COPD.
  • Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospital Pharmacies and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of respiratory diseases globally
      • 5.1.1.2. Rising awareness associated withthe benefits of digital health and connected devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of smart inhalers
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising introduction of novel smart inhalers
      • 5.1.3.2. Digital health partnerships between smart inhaler manufacturers and software companies
    • 5.1.4. Challenges
      • 5.1.4.1. Certain technological limitations with the smart inhaler
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing usage of dry powder inhalers as it simplifies the medication delivery process
    • 5.2.2. Distribution Channel: Growing availability of smart inhalers through online distribution channel
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Inhalers Market, by Product Type

  • 6.1. Introduction
  • 6.2. Dry Powder Inhalers
  • 6.3. Metered-Dose Inhalers

7. Smart Inhalers Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD

8. Smart Inhalers Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
    • 8.2.1. Hospital Pharmacies
    • 8.2.2. Retail Pharmacies
  • 8.3. Online

9. Americas Smart Inhalers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Smart Inhalers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Smart Inhalers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. NHS-Funded Leicester Study Harnesses Smart Inhalers to Enhance Asthma Management Among High-Risk Children, Aiming for Broader Adoption
    • 12.3.2. FDA Clears Innovative Hailie Smartinhaler for AstraZeneca Inhalers
    • 12.3.3. Teva's Smart Inhaler GoResp Digihaler Launches in UK
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Adherium Limited
  • 3. AptarGroup, Inc.
  • 4. Boehringer Ingelheim group
  • 5. Cipla Limited
  • 6. Cognita Labs, LLC
  • 7. Cohero Health, Inc.
  • 8. FindAir Sp. z o. o.
  • 9. GlaxoSmithKline PLC
  • 10. Glenmark Pharmaceuticals
  • 11. Nemera Development S.A.
  • 12. Omron Corporation
  • 13. OPKO Health, Inc.
  • 14. PARI GmbH
  • 15. ResMed Inc.
  • 16. Sensirion Holding AG
  • 17. Teva Pharmaceutical Industries Limited
  • 18. Vectura Group Limited
  • 19. Vectura Group Ltd.

LIST OF FIGURES

  • FIGURE 1. SMART INHALERS MARKET RESEARCH PROCESS
  • FIGURE 2. SMART INHALERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART INHALERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART INHALERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SMART INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SMART INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SMART INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SMART INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART INHALERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART INHALERS MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART INHALERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART INHALERS MARKET SIZE, BY METERED-DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART INHALERS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART INHALERS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART INHALERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMART INHALERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMART INHALERS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SMART INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SMART INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM SMART INHALERS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 187. SMART INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. SMART INHALERS MARKET, FPNV POSITIONING MATRIX, 2023